Skip to main navigation
Supernus Pharmaceuticals

Header Links

  • Return to Supernus.com

Investor Relations

  • Overview
  • News & Events
    Press Releases Events & Presentations
  • Governance
    Corporate Governance Management Board of Directors Committee Composition Contact the Board
  • Financials & Filings
    Financials & Filings SEC Filings Annuals & Proxies Quarterly Results
  • Stock
    Stock Information Historic Stock Lookup Investment Calculator Ownership Profile
  • Contact Us

Investor Relations

  • Overview
  • News & Events
    • Press Releases
    • Events & Presentations
  • Governance
    • Corporate Governance
    • Management
    • Board of Directors
    • Committee Composition
    • Contact the Board
  • Financials & Filings
    • Financials & Filings
    • SEC Filings
    • Annuals & Proxies
    • Quarterly Results
  • Stock
    • Stock Information
    • Historic Stock Lookup
    • Investment Calculator
    • Ownership Profile
  • Contact Us

    Breadcrumb

  1. Investor Relations
  2. Financials & Filings

Financials & Filings

Show all
2026
First Quarter
  • Supernus Pharmaceuticals 1Q 2026 Financial and Business Update Conference Call
  • Supernus Announces First Quarter 2026 Financial Results
  • Form 10-Q
2025
Fourth Quarter
  • Supernus Pharmaceuticals 4Q 2025 Financial and Business Update Conference Call
  • Supernus Announces Record Fourth Quarter and Full Year 2025 Financial Results
  • Form 10-K


Annual Reports
2024 Annual Report
2023 Annual Report
2022 Annual Report


Proxy Statements

Filing date View
April 30, 2026
0001104659-26-053111.pdf
0001104659-26-053111.rtf
0001104659-26-053111.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
April 30, 2026
0001104659-26-053127.pdf
0001104659-26-053127.rtf
View HTML


Form 10-K

Filing date View
April 30, 2026 View HTML
0001104659-26-053143.pdf
0001104659-26-053143.rtf
March 2, 2026 View HTML
0001356576-26-000011.pdf
0001356576-26-000011.rtf
0001356576-26-000011.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA


Form 10-Q

Filing date View
May 5, 2026
0001356576-26-000022.pdf
0001356576-26-000022.rtf
0001356576-26-000022.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML
November 6, 2025
0001356576-25-000071.pdf
0001356576-25-000071.rtf
0001356576-25-000071.xls
EX-101.SCH - XBRL TAXONOMY EXTENSION SCHEMA View HTML

Shareholder Tools


Email Alerts


RSS Feeds


Search

Back to Top
Supernus Pharmaceuticals

Supernus Pharmaceuticals, Inc.
9715 Key West Avenue
Rockville, MD 20850
(301) 838-2500
info@supernus.com

Back to Top

© 2026 Supernus Pharmaceuticals

Post Footer Links

  • Sitemap
  • Terms of Use
  • Privacy Policy
  • Cookie Policy
  • State Policy
  • Social Media Community Guidelines